DailyDoctor Archive Specialties Get app
Back to the 15 September 2026 edition

Regulatory · 01 of 05

Ongoing Class II recall of ready-to-use vancomycin infusion bags

Check your premixed vancomycin stock against the recall, and if you have to prepare it on the ward, post the dilution and the maximum infusion rate at the bedside.

The FDA sweep carries ongoing Class II recalls covering premixed vancomycin injection, 1 g in 200 mL, in both sodium chloride and dextrose single-dose flexible containers, from one manufacturer. The stated reason is deviation from current good manufacturing practice. Class II is the middle classification: use may cause temporary or medically reversible adverse consequences, and the probability of serious harm is remote.

Nothing here is a finding about vancomycin. The consequence is operational, and it is the kind that produces errors rather than alarms. Ready-to-use bags exist because reconstituting and diluting vancomycin on a ward is a multi-step calculation, usually done at speed, often out of hours. When the premix is unavailable, that calculation comes back - and it comes back to staff who may have trained entirely in units where it was never necessary.

Check stock against the notice, and if you are switching to reconstitution, put the concentration, the diluent volume and the maximum infusion rate where the drug is prepared. Rate matters here specifically: vancomycin infusion reactions are rate-dependent, and a nurse improvising a rate is the predictable failure.

  • Audit ward and critical care stock of premixed vancomycin against the current recall notice.
  • If reverting to reconstitution, post the dilution and the maximum infusion rate at the preparation point.
  • Brief staff explicitly on rate-dependent infusion reactions before the first improvised bag is hung.
  • Confirm therapeutic drug monitoring practice is unchanged - the recall does not alter target levels.
  • Raise substitution with pharmacy before stock runs out, not when the shelf is empty.

Why it matters

Withdrawing a ready-to-use presentation quietly reinstates a bedside calculation that most current ward staff have never had to do.

Don't overread it

A Class II recall for manufacturing deviations is a supply action, not evidence that any patient was harmed by the drug.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

antimicrobialresistancerespiratoryinf

Tomorrow morning, before your first patient

One edition a day for infectious diseases, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app